Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Congestive Heart Failure
95%
Acetylsalicylic Acid
93%
Cerebrovascular Accident
64%
Brain Ischemia
54%
Clinical Trial
29%
Systolic Heart Failure
28%
Heart Failure with Reduced Ejection Fraction
25%
Anticoagulant Agent
21%
Diseases
18%
Brain Hemorrhage
17%
Disorders of Mitochondrial Functions
17%
Bleeding
16%
Atrial Fibrillation
15%
Adverse Event
15%
Tenecteplase
14%
Randomized Controlled Trial
14%
Amyotrophic Lateral Sclerosis
14%
Placebo
14%
Mitochondrial DNA
13%
Ubidecarenone
11%
Alteplase
10%
Thymidine Kinase
10%
Gavestinel
9%
Neuroprotection
9%
Glycine Receptor Antagonist
9%
Transient Ischemic Attack
9%
Myopathy
8%
Cause of Death
8%
Randomized Clinical Trial
6%
Phase II Trials
6%
Antithrombotic Therapy
6%
Medicine and Dentistry
Disorders of Mitochondrial Functions
35%
Apoplexy
35%
Warfarin
29%
Acetylsalicylic Acid
26%
Diagnosis
23%
Infarction
22%
Ejection Fraction
21%
Atrial Fibrillation
21%
Systolic Heart Failure
21%
Congestive Heart Failure
21%
Amyotrophic Lateral Sclerosis
19%
Heart Failure with Reduced Ejection Fraction
19%
Diseases
19%
Clinical Trial
19%
Brain Ischemia
18%
Antithrombotic
14%
Odds Ratio
13%
Sinus Rhythm
12%
Carotid Artery Stenosis
12%
Bleeding
12%
Mitochondrial DNA
12%
Rating Scale
11%
Coenzyme Q10
11%
Hazard Ratio
11%
Prospective Study
10%
Cardiovascular System
10%
Transcranial Doppler
9%
Thymidine Kinase
9%
Myopathy
8%
Rare Disease
7%
Outpatient
6%
Ischemia
6%
Phase II Trials
6%
Doppler Flowmetry
6%
Doppler Ultrasound
6%
Stenosis
6%
Thrombus
6%
CHA2DS2-VASc Score
5%
Side Effect
5%
Clinician
5%
Transient Ischemic Attack
5%
Placebo
5%
Post-Hoc Analysis
5%
Dietary Supplement
5%
Nursing and Health Professions
Warfarin
38%
Heart Ejection Fraction
29%
Congestive Heart Failure
28%
Cerebrovascular Accident
24%
Confidence Interval
17%
Atrial Fibrillation
12%
Heart Failure with Reduced Ejection Fraction
11%
Diagnosis
10%
Amyotrophic Lateral Sclerosis
9%
Systolic Heart Failure
9%
Disorders of Mitochondrial Functions
9%
Rating Scale
9%
Odds Ratio
9%
Brain Ischemia
8%
Heart Left Ventricle Ejection Fraction
8%
New York Heart Association Class
7%
Anticoagulant Agent
6%
Rare Disease
5%
Anticoagulation
5%
Post Hoc Analysis
5%
International Normalized Ratio
5%
